Biomarker Biomarqueurs Antisynthetase Inflammation Auto‐antibodies B cell homeostasis Adult Aldosterone Idiopathic inflammatory myopathies Interstitial lung disease COVID-19 Anticorps anti-agalsidase Myositis Cancer Aldostérone Antibodies Female AAV vector Anti-drug antibodies AAV vectors Anti-agalsidase antibodies Sphingosine-1-phosphate Polymyositis Dermatomyositis Anti-IgE IgG Antisynthetase syndrome Inclusion body myositis Immune checkpoint inhibitors Myopathy Anti-Mi2 Bioelectrical impedance analysis Autoimmune diseases Anémie hémolytique Prognosis Autoantibodies Adeno-associated virus Dependovirus/genetics/immunology CD8+T cells Inflammatory myopathy Animals Biopsy Myocarditis Adolescence Autoantibody Case reports Outcome measures Multidisciplinarity Inborn errors of metabolism Anticorps spécifique des myosites Anti-interleukin-6 Amyotrophy Adeno-associated vector B-lymphocyte Acid-alpha-glucosidase Muscle Systems biology AAV antibody Gene therapy Active Agalsidase Cytokines Assisted communication devices Middle Aged Autoimmunity Auto-antibodies Acute Kidney Injury/epidemiology/etiology Interferon CD8+ T-bet+ cells Adjudication Auto-immunité IBM Antiphospholipid syndrome Adeno-associated virus vector Humans Immunotherapy AAV Myositis and muscle disease Analyses multidimensionnelles Lysosomal storage diseases Adverse drug reactions Anti-synthetase syndrome Abnormal movement Mass cytometry Aged Male AAV humoral immunity Skeletal muscle Data integration Antisynthétase Anti‐mitochondrial antibodies Amyotrophic lateral sclerosis Anti-MDA5 autoantibodies DM Deep immune profiling Machine learning IMNM Fabry disease Biomarkers Arthritis Antibody responses